Skip to main content
ATRC
NASDAQ Life Sciences

AtriCure Beats Growth Bar With 15% Revenue Rise, Raises Full-Year Outlook to $610M

Tom Rudovsky · Reported by BusinessWire
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$60.41
Mkt Cap
$3.072B
52W Low
$25.36
52W High
$63
52W Position info
138% above low
Off High info
4.1% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

ATRC has more than doubled off its 52-week low of $25.36.

Summary

AtriCure posted Q3 2026 revenue of $154.5 million, up 15.0% year over year, with U.S. revenue up 17.1% to $128.0 million on cryoSPHERE MAX, EnCompass and AtriClip Mini devices. Gross margin expanded 180 basis points to 77.3%, and adjusted EBITDA jumped 51% to $26.8 million. GAAP net income swung to $4.1 million, or $0.08 per share, from a small loss a year ago; adjusted EPS was $0.18 versus a $0.01 loss, and that adjusted EPS of USD 0.18 came in against an IBES estimate of USD -0.05. Management guided full-year 2026 revenue to roughly $606-610 million and adjusted EBITDA to $91-94 million, with adjusted EPS of $0.40-0.46 and continued positive cash generation. The soft spot is minimally invasive ablation, where sales fell as physicians shift to PFA catheters — a competitive headwind worth tracking against the strength in pain management and appendage management. The stock sits near its 52-week high, so the guidance raise is the number that matters for the tape.

At the time of this announcement, ATRC was trading at $60.41 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.1B. The 52-week trading range was $25.36 to $63.00. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

ATRC - Latest Insights

ATRC
Nov 04, 2026, 2:02 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $64.90
Real-time Price: $55.39 info
Change: -$9.50 (-15%) info
Market Cap: $2.821B info
ATRC
Nov 03, 2026, 4:00 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $60.35
Real-time Price: $55.39 info
Change: -$4.96 (-8%) info
Market Cap: $2.821B info
ATRC
Jul 27, 2026, 1:07 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $37.31
Real-time Price: $55.39 info
Change: +$18.08 (+48%) info
Market Cap: $2.821B info
ATRC
Jul 23, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $34.71
Real-time Price: $55.39 info
Change: +$20.68 (+60%) info
Market Cap: $2.821B info
ATRC
May 19, 2026, 4:21 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $28.80
Real-time Price: $55.39 info
Change: +$26.59 (+92%) info
Market Cap: $2.821B info